Cargando…

Associations between psychiatric disorders, COVID-19 testing probability and COVID-19 testing results: findings from a population-based study

BACKGROUND: Many psychiatrists are worried their patients, at increased risk for COVID-19 complications, are precluded from receiving appropriate testing. There is a lack of epidemiological data on the associations between psychiatric disorders and COVID-19 testing rates and testing outcomes. AIMS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Meer, Dennis, Pinzón-Espinosa, Justo, Lin, Bochao D., Tijdink, Joeri K., Vinkers, Christiaan H., Guloksuz, Sinan, Luykx, Jurjen J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2020
Materias:	Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417998/ https://www.ncbi.nlm.nih.gov/pubmed/32696734 http://dx.doi.org/10.1192/bjo.2020.75

Ejemplares similares

Associations between psychiatric disorders, COVID-19 testing probability and COVID-19 testing results: findings from a population-based study – ERRATUM
por: van der Meer, Dennis, et al.
Publicado: (2020)

Safe and informed prescribing of psychotropic medication during the COVID-19 pandemic
por: Luykx, Jurjen J., et al.
Publicado: (2020)

Selective outcome reporting across psychopharmacotherapy randomized controlled trials
por: Lancee, Michelle, et al.
Publicado: (2021)

Are psychiatric disorders risk factors for COVID-19 susceptibility and severity? a two-sample, bidirectional, univariable, and multivariable Mendelian Randomization study
por: Luykx, Jurjen J., et al.
Publicado: (2021)

Diphtheria And Tetanus Vaccination History Is Associated With Lower Odds of COVID-19 Hospitalization
por: Monereo-Sánchez, Jennifer, et al.
Publicado: (2021)

Use of positive and negative words in scientific PubMed abstracts between 1974 and 2014: retrospective analysis
por: Vinkers, Christiaan H, et al.
Publicado: (2015)

Phenome-wide and genome-wide analyses of quality of life in schizophrenia – ERRATUM
por: Pazoki, Raha, et al.
Publicado: (2021)

Phenome-wide and genome-wide analyses of quality of life in schizophrenia
por: Pazoki, Raha, et al.
Publicado: (2020)

The effects of industry funding and positive outcomes in the interpretation of clinical trial results: a randomized trial among Dutch psychiatrists
por: Tijdink, Joeri K., et al.
Publicado: (2019)

Barriers to genetic testing in clinical psychiatry and ways to overcome them: from clinicians’ attitudes to sociocultural differences between patients across the globe
por: Pinzón-Espinosa, Justo, et al.
Publicado: (2022)

Impact of the first COVID-19 outbreak on mental health service utilisation at a Dutch mental health centre: retrospective observational study
por: Chow, Man Wei, et al.
Publicado: (2021)

A new genetic locus for antipsychotic-induced weight gain: A genome-wide study of first-episode psychosis patients using amisulpride (from the OPTiMiSE cohort)
por: ter Hark, Sophie E, et al.
Publicado: (2020)

Adequate statistical power in clinical trials is associated with the combination of a male first author and a female last author
por: Otte, Willem M, et al.
Publicado: (2018)

Analysis of 567,758 randomized controlled trials published over 30 years reveals trends in phrases used to discuss results that do not reach statistical significance
por: Otte, Willem M., et al.
Publicado: (2022)

Representation and Outcomes of Individuals With Schizophrenia Seen in Everyday Practice Who Are Ineligible for Randomized Clinical Trials
por: Taipale, Heidi, et al.
Publicado: (2022)

Clinical, Biochemical and Genetic Variables Associated With Metabolic Syndrome in Patients With Schizophrenia Spectrum Disorders Using Second-Generation Antipsychotics: A Systematic Review
por: Sneller, Marius H., et al.
Publicado: (2021)

M126. THE MAIN AND INTERACTIVE EFFECTS OF ADULT STRESSFUL LIFE EVENTS WITH GENOMIC AND EXPOSOMIC LIABILITY FOR SCHIZOPHRENIA ON MENTAL AND PHYSICAL HEALTH: A PROSPECTIVE COHORT STUDY
por: Pries, Lotta-Katrin, et al.
Publicado: (2020)

Do Current Measures of Polygenic Risk for Mental Disorders Contribute to Population Variance in Mental Health?
por: Marsman, Anne, et al.
Publicado: (2020)

Context v. algorithm: evidence that a transdiagnostic framework of contextual clinical characterization is of more clinical value than categorical diagnosis
por: van Os, Jim, et al.
Publicado: (2023)

Issues related to testing for COVID-19 in a psychiatric emergency setting
por: Sadh, Kamaldeep, et al.
Publicado: (2020)

Psychiatric morbidity among patients tested positive and isolated for COVID-19
por: Zubair, U.
Publicado: (2021)

“Protect, test, vaccinate”: dealing with Covid-19 in outpatient psychiatric care
por: Psota, G., et al.
Publicado: (2022)

The methodological quality of 176,620 randomized controlled trials published between 1966 and 2018 reveals a positive trend but also an urgent need for improvement
por: Vinkers, Christiaan H., et al.
Publicado: (2021)

A Retrospective Review of COVID-19 Testing and Mitigation Strategies at Psychiatric Hospital and Subsequent COVID-19 Acquisition
por: Klousnitzer, Jessie, et al.
Publicado: (2023)

COVID-19: Test, Test and Test
por: Saleh, Fatima A, et al.
Publicado: (2020)

Psychiatric Clinical Profiles and Pharmacological Interactions in COVID-19 Inpatients Referred to a Consultation Liaison Psychiatry Unit: a Cross-Sectional Study
por: Arbelo, Nestor, et al.
Publicado: (2021)

Probability of encountering Covid-19 patients based on prevalence and testing during resumption of ophthalmology services
por: Keller, Johannes, et al.
Publicado: (2020)

What makes the psychosis ‘clinical high risk’ state risky: psychosis itself or the co-presence of a non-psychotic disorder?
por: Hasmi, Laila, et al.
Publicado: (2021)

Genetic evidence for a large overlap and potential bidirectional causal effects between resilience and well-being
por: de Vries, Lianne P., et al.
Publicado: (2021)

Testing for COVID-19
por: Burki, Talha Khan
Publicado: (2020)

Testing for COVID-19
por: Brischetto, Anna, et al.
Publicado: (2020)

Covid‐19 Control and the Economy: Test, Test, Test
por: Taamouti, Abderrahim
Publicado: (2021)

O4.4. DOES POLYGENIC RISK SCORE FOR SCHIZOPHRENIA MODERATE THE MOMENTARY AFFECTIVE AND PSYCHOTIC REACTIONS TO DAILY-LIFE STRESSORS?
por: Pries, Lotta-Katrin, et al.
Publicado: (2018)

Interpretation of Antigen-detection Rapid Diagnostic Tests (Ag-RDTs) Should Take into Account the Pre-test Probability of COVID-19 Infection
por: Teo, Shyh Poh
Publicado: (2022)

Weekly COVID-19 testing with household quarantine and contact tracing is feasible and would probably end the epidemic
por: Peto, Julian, et al.
Publicado: (2020)

Derivation and validation of a scoring system to assess pre-test probability of being COVID-19 positive
por: Borghetti, A., et al.
Publicado: (2021)

FIND documents dramatic reduction in COVID-19 testing
por: Usher, Ann Danaiya
Publicado: (2022)

A Probable Covid-19 Case Presented with Acute Upper Limb İschemia
por: Erkul, Gulen Sezer Alptekin, et al.
Publicado: (2021)

Considerations on probability tests
por: Peyrou, Charles
Publicado: (1963)

Trends in cholesterol testing during the COVID-19 pandemic: COVID-19 and cholesterol testing
por: Gumuser, Esra D., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4rtjd2bra3vmc9u73pjuji43hl